UNSPSC 51313410: Triprolidine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2L8T9S52QM. European Medicines Agency schedules Triprolidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11323MIG. Triprolidine generally arises in the molecular formula C19H22N2.

UNSPSC 51313410 Triprolidine, a Commodity code, does not appear to match the actual pharmaceutical procurement activity documented in recent state and local opportunities. The code nominally names a single antihistamine molecule, yet the recent opportunities solicited under it involve naloxone procurement, therapeutic pharmacy initiative direct-to-manufacturer programs, and multi-source generic pharmaceutical and OTC product supply agreements — none of which center on triprolidine specifically. State and local procurement offices appear to be tagging broad pharmaceutical supply and community health initiatives with this code rather than triprolidine-specific purchases, creating a mismatch between the code's nominal scope and the work actually being bought.

Recent activity spans a narrow geographic footprint with representation from Florida (Seminole County), Texas (Texas Health and Human Services Commission), and Minnesota (Minnesota Multistate Cooperative Purchasing Alliance). Seminole County issued an IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually on June 30, 2026, with a response deadline of July 26, 2023; the Texas HHS Commission posted an RFI on April 3, 2026, seeking vendor capabilities for a direct-to-manufacturer prescription program; and the Minnesota Department of Administration's Office of State Procurement issued an RFP through MMCAP on January 20, 2026, for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities, with responses due March 26, 2026. The issuing bodies are primarily state health and human services departments and county health agencies, with cooperative purchasing vehicles used to aggregate demand across jurisdictions. Given the code-scope mismatch and the limited number of documented opportunities, this code shows little targeted recent activity relevant to triprolidine procurement specifically.